AllNewsPhotosVideos
Serum Institute of India

Serum Institute Of India Pvt. Ltd

Serum institute of india pvt. ltd, Latest News

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.
Read More
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine - Hindi News | Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine | Latest health News at Lokmattimes.com

Health :Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine

Hyderabad, Dec 20 Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to ... ...

Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval - Hindi News | Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval | Latest international News at Lokmattimes.com

International :Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval

After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19. ...

Nandan Terry filed DRHP for its maiden IPO of upto Rs. 254.96 Crores through Jaipur based, investment banker, Holani Consultants Pvt. Ltd. - Hindi News | Nandan Terry filed DRHP for its maiden IPO of upto Rs. 254.96 Crores through Jaipur based, investment banker, Holani Consultants Pvt. Ltd. | Latest business News at Lokmattimes.com

Business :Nandan Terry filed DRHP for its maiden IPO of upto Rs. 254.96 Crores through Jaipur based, investment banker, Holani Consultants Pvt. Ltd.

Ahmedabad based company, Nandan Terry Limited, belonging to Chiripal group, a textile conglomerate, filed draft offer document with the regulators. ...

Bajaj Allianz General Insurance launches '#Care4Hockey' campaign - Hindi News | Bajaj Allianz General Insurance launches '#Care4Hockey' campaign | Latest business News at Lokmattimes.com

Business :Bajaj Allianz General Insurance launches '#Care4Hockey' campaign

Bajaj Allianz General Insurance, one of the leading private general insurers in India today announced the launch of its '#Care4Hockey' campaign. ...

Serum Institute's executive director Suresh Jadhav passes away - Hindi News | Serum Institute's executive director Suresh Jadhav passes away | Latest national News at Lokmattimes.com

National :Serum Institute's executive director Suresh Jadhav passes away

Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday. ...

Dr S.S. Jadhav, who helped develop SII's Covishield, dies in Pune - Hindi News | Dr S.S. Jadhav, who helped develop SII's Covishield, dies in Pune | Latest health News at Lokmattimes.com

Health :Dr S.S. Jadhav, who helped develop SII's Covishield, dies in Pune

Pune, Dec 8 Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav ... ...

RDIF ready to provide one-shot Sputnik Light vaccine, Sputnik M vaccine to India for adolescents - Hindi News | RDIF ready to provide one-shot Sputnik Light vaccine, Sputnik M vaccine to India for adolescents | Latest international News at Lokmattimes.com

International :RDIF ready to provide one-shot Sputnik Light vaccine, Sputnik M vaccine to India for adolescents

The Russian Direct Investment Fund (Russia's sovereign wealth fund) has said that it strives to expand the partnership between Russia and India in the fight against COVID by providing the one-shot Sputnik Light vaccine and Sputnik M vaccine (for adol ...

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns - Hindi News | SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns | Latest national News at Lokmattimes.com

National :SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country, officials informed ANI on Thursday. ...